{"id":121983,"date":"2024-11-04T14:24:44","date_gmt":"2024-11-04T07:24:44","guid":{"rendered":"https:\/\/hotvideos24.online\/?p=121983"},"modified":"2024-11-04T14:24:44","modified_gmt":"2024-11-04T07:24:44","slug":"scientist-behind-ozempic-started-her-career-developing-laundry-detergent-60-minutes","status":"publish","type":"post","link":"https:\/\/hotvideos24.online\/?p=121983","title":{"rendered":"Scientist behind Ozempic started her career developing laundry detergent | 60 Minutes"},"content":{"rendered":"<p> <script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-3711241968723425\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-format=\"fluid\"\r\n     data-ad-layout-key=\"-fb+5w+4e-db+86\"\r\n     data-ad-client=\"ca-pub-3711241968723425\"\r\n     data-ad-slot=\"7910942971\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><br \/>\n<\/p>\n<div id=\"\">\n<p>Ozempic and Wegovy may not have been developed if not for the insistence of Novo Nordisk&#8217;s head of research, Mads Krogsgaard.<\/p>\n<p>Leadership at the Danish company in the early 1990s were skeptical about developing drugs to treat obesity. Krogsgaard saw things differently.\u00a0<\/p>\n<p>&#8220;I started trying to convince them that it&#8217;s not getting on the bike,&#8221; Krogsgaard said. &#8220;If you&#8217;re genetically predisposed, living in the environment we are in today, you are at very high risk. And something should be done about that.&#8221;<\/p>\n<aside class=\"newsletter_signup \">\n<figure class=\"embed embed--type-newsletter-widget embed--float-none embed--size-large embed--type-iframe\" data-ads=\"{\" wordcount=\"\">\n<\/figure>\n<\/aside>\n<p>Novo Nordisk now makes <span class=\"link\"><a href=\"https:\/\/www.cbsnews.com\/news\/wegozy-ozempic-explainer-60-minutes-2023-01-01\/\" target=\"_blank\" data-invalid-url-rewritten-http=\"\" rel=\"noopener\">Ozempic and Wegovy<\/a><\/span>, prescription drugs used to treat Type 2 diabetes and obesity, which have become wildly popular.<\/p>\n<h2>From diabetes to laundry detergent to weight loss\u00a0<\/h2>\n<p>While Krogsgaard\u00a0 convinced company leadership to study <span class=\"link\"><a href=\"https:\/\/www.cbsnews.com\/news\/weight-loss-obesity-drug-2023-01-01\/\" target=\"_blank\" data-invalid-url-rewritten-http=\"\" rel=\"noopener\">obesity<\/a><\/span> drugs, it was Lotte Knudsen who made breakthroughs in the research. Her first job at Novo Nordisk was on the enzyme team researching ways of making sure reds and whites didn&#8217;t run in the wash. She views her research on detergent and obesity the same way.\u00a0<\/p>\n<figure class=\"embed embed--type-image is-image embed--float-none embed--size-medium\"><span class=\"img embed__content\"><img alt=\"Lotte Knudsen \" height=\"349\" width=\"620\" class=\" lazyload\" srcset=\"https:\/\/assets3.cbsnewsstatic.com\/hub\/i\/r\/2024\/10\/30\/b1f206a1-9f9b-4ffd-9fff-1f0a06aac7ce\/thumbnail\/620x349\/384d6f66c4be7fd9942bba40c5109766\/lotte-bjerre-knudsen-int-ms001.jpg?v=379420b9063a2aadbcd559df18e2d1ae 1x, https:\/\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2024\/10\/30\/b1f206a1-9f9b-4ffd-9fff-1f0a06aac7ce\/thumbnail\/1240x698\/b7d6436cee3ab796a0e2c6eec99194fa\/lotte-bjerre-knudsen-int-ms001.jpg?v=379420b9063a2aadbcd559df18e2d1ae 2x\"\/><\/span><figcaption class=\"embed__caption-container\"><span class=\"embed__caption\">Lotte Knudsen<\/span><\/p>\n<p>                  <span class=\"embed__credit\"><\/p>\n<p>                60 Minutes<\/p>\n<p>                          <\/span><br \/>\n              <\/figcaption><\/figure>\n<p>&#8220;It&#8217;s the same story, right, of just wanting to make a product that&#8217;s useful,&#8221; Knudsen said.<\/p>\n<p>In the early 90s, she came across a study about GLP-1, a naturally occurring gut hormone that lowered blood sugar levels and suppressed appetite. Knudsen thought that if GLP-1 could be harnessed into a drug, it could revolutionize treatment for both diabetes and obesity. She took the study to her boss, head of research Mads Krogsgaard.<\/p>\n<p>&#8220;She was the first one to march into my office, with red hair, and very fired up, showing me a publication that was not even published yet,&#8221; Krogsgaard said. &#8220;She was talking very agitatedly about this. And I was getting excited.&#8221;<\/p>\n<p>Novo Nordisk spent the next 20 years working on that GLP-1 molecule before Ozempic finally made it to market as a Type 2 diabetes drug in 2017. It took another four years for Wegovy to be approved for weight loss.\u00a0<\/p>\n<figure class=\"embed embed--type-image is-image embed--float-none embed--size-medium\"><span class=\"img embed__content\"><img alt=\"Mads Krogsgaard \" height=\"349\" width=\"620\" class=\" lazyload\" srcset=\"https:\/\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2024\/10\/30\/9a526d94-a3ef-49f6-a28e-acd4bb18c1ae\/thumbnail\/620x349\/78b64a6afe445eea44b59cfdce2d88cb\/mads-krogsgaard-intv-ms-gesture001.jpg?v=379420b9063a2aadbcd559df18e2d1ae 1x, https:\/\/assets2.cbsnewsstatic.com\/hub\/i\/r\/2024\/10\/30\/9a526d94-a3ef-49f6-a28e-acd4bb18c1ae\/thumbnail\/1240x698\/8d8f45f4184a787f6c52bf8f7023e4d0\/mads-krogsgaard-intv-ms-gesture001.jpg?v=379420b9063a2aadbcd559df18e2d1ae 2x\"\/><\/span><figcaption class=\"embed__caption-container\"><span class=\"embed__caption\">Mads Krogsgaard<\/span><\/p>\n<p>                  <span class=\"embed__credit\"><\/p>\n<p>                60 Minutes<\/p>\n<p>                          <\/span><br \/>\n              <\/figcaption><\/figure>\n<p>The drugs turned Novo Nordisk from a niche player into a company bigger than Exxon Mobil and Procter &amp; Gamble. With a market cap of $600 billion, Novo Nordisk is now Europe&#8217;s largest company.\u00a0<\/p>\n<p>Despite the meteoric success of the drugs she helped develop, Knudsen still considers herself a &#8220;nerdy little scientist who kind of found home here in this company for 35 years.&#8221;<\/p>\n<p>    <!-- data-recirc-source=\"chartbeat\" --><\/p>\n<aside class=\"component list recirculation component--type-recirculation \"\/><!-- tags --><\/p>\n<div class=\"content-author\">\n      <a href=\"https:\/\/www.cbsnews.com\/team\/l-jon-wertheim\/\" class=\"content-author__name\" data-invalid-url-rewritten-http=\"\">Jon Wertheim<\/a><\/p>\n<div class=\"content-author__bio\">\n<div class=\"content-author__image\">\n            <a href=\"https:\/\/www.cbsnews.com\/team\/l-jon-wertheim\/\" data-invalid-url-rewritten-http=\"\"><br \/>\n              <span class=\"img \"><img alt=\"headshot-600-l-jon-wertheim.jpg \" height=\"80\" width=\"80\" class=\" lazyload\" srcset=\"https:\/\/assets3.cbsnewsstatic.com\/hub\/i\/r\/2024\/05\/17\/87e3dcae-821d-4498-b4df-8439f2a54419\/thumbnail\/80x80\/3a6c81cd41fdacbf43e12147074f29d3\/headshot-600-l-jon-wertheim.jpg?v=379420b9063a2aadbcd559df18e2d1ae 1x, https:\/\/assets3.cbsnewsstatic.com\/hub\/i\/r\/2024\/05\/17\/87e3dcae-821d-4498-b4df-8439f2a54419\/thumbnail\/160x160\/0c25a9b7d7a20568c6b212e919488d39\/headshot-600-l-jon-wertheim.jpg?v=379420b9063a2aadbcd559df18e2d1ae 2x\"\/><\/span><br \/>\n            <\/a>\n          <\/div>\n<div class=\"content-author__full-information\">\n<p class=\"content-author__text\">L. Jon Wertheim is an accomplished journalist and 60 Minutes correspondent.<\/p>\n<\/p><\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/p><\/div>\n<p><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-3711241968723425\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-format=\"fluid\"\r\n     data-ad-layout-key=\"-fb+5w+4e-db+86\"\r\n     data-ad-client=\"ca-pub-3711241968723425\"\r\n     data-ad-slot=\"7910942971\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><br \/>\n<br \/><div data-type=\"_mgwidget\" data-widget-id=\"1660802\">\r\n<\/div>\r\n<script>(function(w,q){w[q]=w[q]||[];w[q].push([\"_mgc.load\"])})(window,\"_mgq\");\r\n<\/script>\r\n<br \/>\n<br \/><a href=\"https:\/\/www.cbsnews.com\/news\/ozempic-wegovy-lotte-knudsen-novo-nordisk-research-60-minutes\/\">Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ozempic and Wegovy may not have been developed if not for the insistence of Novo Nordisk&#8217;s head of research, Mads Krogsgaard. Leadership at the Danish company in the early 1990s &hellip; <a href=\"https:\/\/hotvideos24.online\/?p=121983\" class=\"more-link\">Read More<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-121983","post","type-post","status-publish","format-standard","hentry","category-health","entry"],"_links":{"self":[{"href":"https:\/\/hotvideos24.online\/index.php?rest_route=\/wp\/v2\/posts\/121983","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hotvideos24.online\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hotvideos24.online\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hotvideos24.online\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/hotvideos24.online\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=121983"}],"version-history":[{"count":0,"href":"https:\/\/hotvideos24.online\/index.php?rest_route=\/wp\/v2\/posts\/121983\/revisions"}],"wp:attachment":[{"href":"https:\/\/hotvideos24.online\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=121983"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hotvideos24.online\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=121983"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hotvideos24.online\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=121983"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}